AI expert joins the panel for Active Surveillance 25
Register for the front row--Happy 2025 and Thanksgiving.
By Howard Wolinsky
Artificial Intelligence is the buzz throughout the prostate cancer world. An AI expert will be featured at the Active Surveillance ‘25 event to discuss what’s new in low-risk disease at noon Eastern on Saturday, Jan. 24, 2025.
Tim Showalter, MD, MPH, Chief Medical Officer of ArteraAI, the leading AI firm, will join the panel and discu…
Keep reading with a 7-day free trial
Subscribe to The Active Surveillor to keep reading this post and get 7 days of free access to the full post archives.